T cell responses against tumor associated antigens and prognosis in colorectal cancer patients
<p>Abstract</p> <p>Introduction</p> <p>Spontaneous T cell responses against specific tumor-associated antigens (TAA) are frequently detected in peripheral blood of tumor patients of various histiotypes. However, little is known about whether these circulating, spontaneo...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://www.translational-medicine.com/content/3/1/3 |
id |
doaj-b584b457775d4a498efea4c439979ad7 |
---|---|
record_format |
Article |
spelling |
doaj-b584b457775d4a498efea4c439979ad72020-11-25T00:17:07ZengBMCJournal of Translational Medicine1479-58762005-01-0131310.1186/1479-5876-3-3T cell responses against tumor associated antigens and prognosis in colorectal cancer patientsRivoltini LiciaHegewisch-Becker SusannaBuhr Heinz-JohannesGermer Christoph-ThomasLetsch AnneScheibenbogen CarmenNagorsen DirkThiel EckhardKeilholz Ulrich<p>Abstract</p> <p>Introduction</p> <p>Spontaneous T cell responses against specific tumor-associated antigens (TAA) are frequently detected in peripheral blood of tumor patients of various histiotypes. However, little is known about whether these circulating, spontaneously occurring, TAA-reactive T cells influence the clinical course of disease.</p> <p>Methods</p> <p>Fifty-four HLA-A2 positive colorectal cancer patients had been analyzed for the presence of T cell responses against epitopes derived from the TAA Ep-CAM, her-2/<it>neu</it>, and CEA either by ELISPOT assay or by intracellular cytokine staining. Then, Kaplan-Meier survival analysis was performed comparing T-cell-responders and T-cell-non-responders. For comparison, a group of T-cell-non-responders was compiled stringently matched to T-cell-responders based on clinical criteria and also analyzed for survival.</p> <p>Results</p> <p>Sixteen out of 54 patients had a detectable T cell response against at least one of the three tested TAA. Two out of 21 patients (9.5%) with limited stage of disease (UICC I and II) and 14 out of 33 patients (42.4%) with advanced disease (UICC III and IV) were T cell response positive. Comparing all T-cell-responders (n = 16) and all T-cell-non-responders (n = 38), no survival difference was found. In an attempt to reduce the influence of confounding clinical factors, we then compared 16 responders and 16 non-responders in a matched group survival analysis; and again no survival difference was found (p = 0.7).</p> <p>Conclusion</p> <p>In summary, we found no evidence that spontaneous peripheral T cell responses against HLA-A2-binding epitopes of CEA, her-2/neu and Ep-CAM are a strong prognostic factor for survival.</p> http://www.translational-medicine.com/content/3/1/3T cell responseantigencolorectal cancersurvivalprognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rivoltini Licia Hegewisch-Becker Susanna Buhr Heinz-Johannes Germer Christoph-Thomas Letsch Anne Scheibenbogen Carmen Nagorsen Dirk Thiel Eckhard Keilholz Ulrich |
spellingShingle |
Rivoltini Licia Hegewisch-Becker Susanna Buhr Heinz-Johannes Germer Christoph-Thomas Letsch Anne Scheibenbogen Carmen Nagorsen Dirk Thiel Eckhard Keilholz Ulrich T cell responses against tumor associated antigens and prognosis in colorectal cancer patients Journal of Translational Medicine T cell response antigen colorectal cancer survival prognosis |
author_facet |
Rivoltini Licia Hegewisch-Becker Susanna Buhr Heinz-Johannes Germer Christoph-Thomas Letsch Anne Scheibenbogen Carmen Nagorsen Dirk Thiel Eckhard Keilholz Ulrich |
author_sort |
Rivoltini Licia |
title |
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients |
title_short |
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients |
title_full |
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients |
title_fullStr |
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients |
title_full_unstemmed |
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients |
title_sort |
t cell responses against tumor associated antigens and prognosis in colorectal cancer patients |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2005-01-01 |
description |
<p>Abstract</p> <p>Introduction</p> <p>Spontaneous T cell responses against specific tumor-associated antigens (TAA) are frequently detected in peripheral blood of tumor patients of various histiotypes. However, little is known about whether these circulating, spontaneously occurring, TAA-reactive T cells influence the clinical course of disease.</p> <p>Methods</p> <p>Fifty-four HLA-A2 positive colorectal cancer patients had been analyzed for the presence of T cell responses against epitopes derived from the TAA Ep-CAM, her-2/<it>neu</it>, and CEA either by ELISPOT assay or by intracellular cytokine staining. Then, Kaplan-Meier survival analysis was performed comparing T-cell-responders and T-cell-non-responders. For comparison, a group of T-cell-non-responders was compiled stringently matched to T-cell-responders based on clinical criteria and also analyzed for survival.</p> <p>Results</p> <p>Sixteen out of 54 patients had a detectable T cell response against at least one of the three tested TAA. Two out of 21 patients (9.5%) with limited stage of disease (UICC I and II) and 14 out of 33 patients (42.4%) with advanced disease (UICC III and IV) were T cell response positive. Comparing all T-cell-responders (n = 16) and all T-cell-non-responders (n = 38), no survival difference was found. In an attempt to reduce the influence of confounding clinical factors, we then compared 16 responders and 16 non-responders in a matched group survival analysis; and again no survival difference was found (p = 0.7).</p> <p>Conclusion</p> <p>In summary, we found no evidence that spontaneous peripheral T cell responses against HLA-A2-binding epitopes of CEA, her-2/neu and Ep-CAM are a strong prognostic factor for survival.</p> |
topic |
T cell response antigen colorectal cancer survival prognosis |
url |
http://www.translational-medicine.com/content/3/1/3 |
work_keys_str_mv |
AT rivoltinilicia tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT hegewischbeckersusanna tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT buhrheinzjohannes tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT germerchristophthomas tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT letschanne tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT scheibenbogencarmen tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT nagorsendirk tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT thieleckhard tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients AT keilholzulrich tcellresponsesagainsttumorassociatedantigensandprognosisincolorectalcancerpatients |
_version_ |
1725381028825006080 |